Vizio sued LeEco in the wake of the Chinese technology conglomerate’s failed attempt at a US$2 billion acquisition of the US television maker.
Vizio seeks US$60 million in damages, claiming LeEco paid only US$40 million of a US$100 million termination fee and didn’t live up to its end of a joint-venture agreement the companies struck after the failed merger.
After the merger fell through in April, the companies agreed to set up a venture to sell Vizio’s products in China through LeEco’s distribution, according to the Irvine, California-based company’s complaint filed Tuesday in nearby Santa Ana federal court. Vizio renounced immediate payment of the termination fee on the condition it would receive US$40 million initially, plus US$10 million at a later point, and Beijing-based LeEco would invest US$50 million in their joint venture, according to the complaint.
When Vizio tried to work out further terms of the framework agreement, it was met with “radio silence,” the company said. LeEco used the proposed joint venture as a subterfuge to escape the US$100 million liability, according to Vizio.
Full Content: The Verge
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas